OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-12-31-accounts

Charity registration number 1032256

THE ASSOCIATION OF CANCER PHYSICIANS

ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

THE ASSOCIATION OF CANCER PHYSICIANS

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Dr A Jones
Professor R Begent
Secretary Prof. S Ahmed
Charity number 1032256
Principal address c/o Mrs A Norton
Department of Medicine
Royal Marsden Hospital
Downs Road, Sutton
Surrey
SM2 5PT
Independent examiner Rouse Partners LLP
55 Station Road
Beaconsfield
Buckinghamshire
HP9 1QL
Bankers National Westminster Bank Plc

THE ASSOCIATION OF CANCER PHYSICIANS

CONTENTS

Page
Trustees report 1 - 3
Independent examiner's report 4
Statement of financial activities 5
Balance sheet 6
Notes to the accounts 7 - 12

THE ASSOCIATION OF CANCER PHYSICIANS

TRUSTEES REPORT FOR THE YEAR ENDED 31 DECEMBER 2022

The trustees present their annual report and financial statements for the year ended 31 December 2022.

The accounts have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the constitution's governing document, the Charities Act 2011 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015)”

Objectives and activities

The objectives of the Association of Cancer Physicians (ACP) are to advance the study and practice of cancer medicine (medical oncology), to represent the interests of medical oncologists and to foster the raising of standards in medical care for cancer patients. It is also the aim to facilitate contact between members of the Association and other individuals and organisations concerned with the study and treatment of cancer and with the public at large.

Applications for membership are approved by the Executive Committee and ratified at the AGM. Members and officers of the Executive Committee are nominated by the membership in line with the Constitution and Rules (updated 2013) and a vote of eligible members is organised in the event of a surplus of nominations for the vacant positions. The Chair is appointed for a period of three years that may be extended for a second term of office. The Executive Committee includes Officers in addition to regional representatives and other designated roles. There are up to three representatives of Cancer Physicians in training and one representative of the New Consultants Group on the Executive Committee. Professor David Cunningham took over as Chair of the ACP in November 2017 and Professor Samreen Ahmed is the current Honorary Secretary. Professor Helena Earl is the Honorary President.

The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the constitution should undertake.

Achievements and performance

During 2022, the Association of Cancer Physicians continued to support a wide range of activities to advance the study and practice of cancer medicine and to help raise standards of medical care for patients.

The ACP contracts with SAS, an association management company, to provide support for the organisation of the ACP’s programme of educational events, in addition to managing its membership activities and collection of subscriptions. The ACP AGM was held remotely by Zoom in October 2022, with good attendance. The Executive Committee has found that a virtual AGM helps to facilitate better participation and interaction with the membership from across the UK, in addition to reducing travel for members and reducing costs for all. The meeting is also recorded for members unable to join the live event.

Involvement in cancer physician training, including teaching and education, remains a high priority for the ACP and 2022 saw the return to face to face events, which had been forced to be cancelled in 2020 and 2021 due to COVID. There was a very successful and relevant workshop on biotherapies, followed by the annual weekend for trainees held in Leeds in October 2022, both of which were well attended. The workshop highlighted some of the new advances in the rapidly expanding field of biotherapies. This included immunotherapies and novel indications, cellular therapies and technologies, as well as oncolytic viruses and advances in liquid biopsies. Presentations by leading experts were facilitated with case-based discussion and interactive panel discussions regarding developments and patients' cancer care

The ACP has been closely involved in the revision of the medical oncology curriculum, overseen by the JRCPTB, as required by the GMC, with the new curriculum implemented in August 2021. Trainees in medical oncology have to take and pass an exam (Specialist Certificate Exam – SCE), to demonstrate that they have sufficient knowledge to practise safely and competently as consultants.

To provide trainees with additional support with studying for the exam, the ACP also prepared a new evidencebased resource to aid revision and support further learning, The publication was expertly overseen by Dr Daniel Hughes, a medical oncology trainee, supported by an editorial board of consultants., and was published on schedule in July 2022, to support revision for the exam in September 2022. It was very well received. The ACP supported the costs of this publication and an agreement with the publishers, EBN Health, also allowed members to benefit from a discount on the purchase price.

THE ASSOCIATION OF CANCER PHYSICIANS

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2022

The ACP continues to advocate for an expansion in the cancer workforce. Demand for systemic therapy has been increasing year on year, and this growth is expected to continue, due to the pressures of an aging population, an increased incidence of cancer, combined with welcome advances in genomics and new therapeutic options. The specialty welcomed a further significant increase in specialty training numbers in medical oncology allocated in 2022, however feels strongly that this expansion needs to be continued in future years to develop a workforce to deliver world leading cancer services in the future. The ACP is planning a comprehensive workforce census to capture the medical oncology/chemotherapy prescribing workforce, with the granularity that should be very helpful in future workforce planning.

As in previous years, excellence in research amongst trainees is encouraged by the award of two annual McElwain prizes, one for a clinical project and one for translational research, in addition to a President’s Prize. The three prizewinners presented their work to their peers at the annual ACP trainees’ weekend in Leeds, in addition to receiving a financial reward. Unfortunately, the annual National Cancer Research Institute (NCRI)’ s flagship conference has ceased operation, denying the prizewinners the opportunity to present there.

With the ongoing reduction in many local, regional and national teaching opportunities following the COVID-19 pandemic, the ACP continued their series of monthly teaching webinars, started in 2020, and included a joint session with the Association of Palliative Medicine, which was also attended by their members. The webinars are supported by pharmaceutical sponsorship and continue to attract sizeable attendances and excellent feedback. The recordings of all the webinars are edited and made available free of charge to all ACP members.

The ACP continues to work closely with EBN Health, an experienced healthcare publishing company, to produce and support its publications. These have been very successful, , with the 2021 publication,, Problem Solving in Cancer and Fertility, a joint venture between the ACP and colleagues in obstetrics and gynaecology, awarded the BMA Oncology Prize in 2022.. The ACP and EBN Health have also established a digital platform as an educational resource to benefit members. This allows access to the full content of the ACP/EBN publications and also includes recordings from the teaching webinars.

The ACP has a reciprocal membership agreement with ESMO (European Society for Medical Oncology), and ESMO representatives sit on the ACP Executive Committee. The ACP collaborates closely with ESMO, and ACP members benefit from a reduced membership subscription to ESMO in addition to access to their extensive programme of activities to support career development.

The ACP continues to be closely involved with and is a parent body of the UK Chemotherapy Board (UKCB), which provides guidance, oversight and support for the continuing development of systemic therapy services across the UK. The UKCB hosts an annual meeting focused on Commissioning Chemotherapy Services, which is well attended.. The UKCB has overseen the development of national regimen specific consent forms for patients undergoing chemotherapy and has established workstreams to undertake audits and produce national guidance and patient-supporting materials to support improvements in the delivery of systemic therapy in the UK.

The ACP is also a member of the Inequalities in Health Alliance, a muti-professional collaborative group launched by the RCP in 2020, to campaign for a cross-government strategy to address and reduce health inequalities.

Since 2019, Working Groups from the ACP, the Royal Colleges of Physicians and The Royal College of Radiologists (RCR) have been exploring the benefits - to patients, the NHS and to clinicians – of closer working between the two specialties of Clinical Oncology and Medical Oncology. The initial exploration of closer working and closer alignment in training in clinical oncology and medical oncology resulted in a common first year of training in both specialties, implemented in August 2021. Discussions and consultation with members and other stakeholders have continued in 2022, with the shared goal of:

After wide ranging analysis and consultations, a Closer Working Group concluded that the best eventual solution would be for Clinical Oncology and Medical Oncology to remain as two separate specialties but to form a new Joint Faculty, hosted within the RCR. Discussions are ongoing, with the current plan to put the proposal of a new Joint Faculty to a vote of both ACP and RCR memberships.

THE ASSOCIATION OF CANCER PHYSICIANS

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2022

Financial review

Financially, the ACP's main source of income is from members subscriptions, with additional sponsorship and educational grants from the pharmaceutical industry to support educational activities. SAS is contracted to manage the ACP’s educational meetings, in additional to maintaining the membership database and responsibility for the collection of subscription income. It is hoped that this will maximise subscription income going forward. The current account runs in credit. Travel costs incurred by Executive members and secretarial costs are the main expenditures, although travel continued to be severely restricted in 2022, with a move to meetings being held virtually. Further substantial expenditure was on educational events and publishing activities supported by receipt of restricted and unrestricted Educational Grants and sponsorships.

Reserves Policy

The association ensures there is sufficient money to meet its annual commitments. A separate fund entitled the McElwain Fund also exists for the presentation of prizes and scholarships in respect of studies to advance the objectives of the association.

At the year end unrestricted reserves were £66,691 (2021: £66,277) and restricted reserves were £45,115 (2021: £65,231).

The trustees have assessed the major risks to which the constitution is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.

Structure, governance and management

The Association of Cancer Physicians was set up in 1985 and then formally adopted the constitution on 29 March 1993 and was registered by the charity commission on 28 January 1994 (charity number 1032256).

The trustees who served during the year were: Dr A Jones Professor R Begent

New trustees are appointed by the Executive Committee and 2-3 nominations were made this year who are being approached about serving in this capacity. Particular emphasis is placed upon the appointment of trustees with knowledge and experience relevant to the charity's charitable activities as well as other trustees with the specialty to offer complementary skills eg accounting and marketing.

Public Benefit Statement

Guidance from the Charity Commission has been used to review and develop The Association of Cancer Physicians aims and objectives so that activities are clearly focused to derive good public benefit.

The trustees report was approved by the Board of Trustees.

.............................. Dr A Jones

Date: .............................................

THE ASSOCIATION OF CANCER PHYSICIANS

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF THE ASSOCIATION OF CANCER PHYSICIANS

I report to the trustees on my examination of the financial statements of The Association of Cancer Physicians (the constitution) for the year ended 31 December 2022.

Responsibilities and basis of report

As the trustees of the constitution you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (the 2011 Act).

I report in respect of my examination of the constitution’s financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Rouse Partners LLP

55 Station Road Beaconsfield Buckinghamshire HP9 1QL

Dated: .........................

THE ASSOCIATION OF CANCER PHYSICIANS

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2022

Unrestricted
Restricted
funds
funds
2022
2022
Notes
£
£
Income and endowments from:
Donations and
legacies
2
43,464
58,750
Investments
3
-
7
Other income
4
997
-
Total income
44,461
58,757
Expenditure on:
Charitable activities
5
44,047
78,873
Net income/(expenditure)
for the year/
Net movement in funds
414
(20,116)
Fund balances at 1 January
2022
66,277
65,231
Fund balances at 31
December 2022
66,691
45,115		 Total
Unrestricted
Restricted
funds
funds
2022
2021
2021
£
£
£
102,214
68,420
71,492
7
-
1
997
-
-
103,218
68,420
71,493
122,920
68,621
58,299
(19,702)
(201)
13,194
131,508
66,478
52,037
111,806
66,277
65,231		 Total
2021
£
139,912
1
-
Donations and
legacies
2
Investments
3
Other income
4
Total income
Expenditure on:
Charitable activities
5
Net income/(expenditure)
for the year/
Net movement in funds
Fund balances at 1 January
2022
Fund balances at 31
December 2022
139,913
126,920
12,993
118,515
131,508

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

THE ASSOCIATION OF CANCER PHYSICIANS

BALANCE SHEET

AS AT 31 DECEMBER 2022

Notes
Current assets
Debtors
10
Cash at bank and in hand
Creditors: amounts falling due within
one year
11
Net current assets
Income funds
Restricted funds
12
Unrestricted funds		 2022
£
24,094
90,490
114,584
(2,778)		 £
111,806
45,115
66,691
111,806		 2021
£
28,543
106,118
134,661
(3,153)		 £
131,508
65,231
66,277
131,508

The financial statements were approved by the Trustees on .........................

.............................. Dr A Jones Trustee

THE ASSOCIATION OF CANCER PHYSICIANS

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

1 Accounting policies

Company information

The Association of Cancer Physicians is an unincorporated association, constituted under a Governing Document dated 29 March 1993 and is a registered charity in the United Kingdom reference 1032256. The address of the registered office is given on the legal and administrative information page of these financial statements.

1.1 Accounting convention

These accounts have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”), “Accounting and Reporting by Charities” the Statement of Recommended Practice for charities applying FRS 102, the Charities Act 2011 and UK Generally Accepted Accounting Practice as it applies from 1 January 2015. The constitution has taken advantage of the provisions in the SORP for charities applying FRS 102 Update Bulletin 1 not to prepare a Statement of Cash Flows. The constitution is a Public Benefit Entity as defined by FRS 102.

The financial statements are prepared in sterling, which is the functional currency of the constitution. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the constitution has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Incoming resources

Income is recognised when the constitution is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

All incoming resources are included in the Statement of Financial Activities (SOFA) when receivable.

Grants receivable are recognised when all performance conditions are satisfied and they have been received.

THE ASSOCIATION OF CANCER PHYSICIANS

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2022

1 Accounting policies

(Continued)

1.5 Resources expended

All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Expenditure is recognised where there is a legal or constructive obligation to make payments to third parties, it is probable that the settlement will be required and the amount of the obligation can be measured reliably. It is categorised under the following headings:

Expenditure on charitable activities includes support and governance costs which are incurred in running the charity.

Support costs are those that assist the work of the charity and include office costs, governance costs and administrative costs. They are incurred directly in support of expenditure on the objects of the charity and allocated to expenditure on charitable activities on a basis consistent with use of the resources.

All expenditure is accounted for on an accruals basis and includes irrecoverable VAT. Direct costs are allocated to the particular activity.

1.6 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7 Financial instruments

The constitution has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the constitution's balance sheet when the constitution becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are recognised at transaction.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

Derecognition of financial liabilities

Financial liabilities are derecognised when the constitution’s contractual obligations expire or are discharged or cancelled.

THE ASSOCIATION OF CANCER PHYSICIANS

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2022

2 Donations and legacies

Unrestricted Restricted Total Total
funds funds 2022 2021
£ £ £ £
Grants 14,844 58,750 73,594 93,492
Membership fees & sponsorships 28,620 - 28,620 46,420
43,464 58,750 102,214 139,912
For the year ended 31 December 2021 68,420 71,492 139,912
3 Investments
Restricted Restricted
funds funds
2022 2021
£ £
Interest receivable 7 1
4 Other income
Unrestricted Total
funds
2022 2021
£ £
Royalties 997 -
5 Charitable activities
2022 2021
£ £
Prizes 3,000 3,300
Meeting and Travel Expenses 79,123 95,941
Publishing Services 22,500 9,000
104,623 108,241
Share of governance costs 18,297 18,679
122,920 126,920

THE ASSOCIATION OF CANCER PHYSICIANS

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2022

6 Support costs

Support
costs
Governance
costs
£
£
Secretarial Services
-
14,607
Independent examination
-
2,775
Sundry expenses
-
858
Bank charges
-
57
-
18,297
Analysed between
Charitable activities
-
18,297		 2022
£
14,607
2,775
858
57
18,297
18,297		 2021 Basis of allocation
£
15,459 Governance
3,150 Governance
- Governance
70 Governance
18,679
18,679

7 Trustees

None of the trustees (or any persons connected with them) received any remuneration during the year.

8 Employees

The average monthly number of employees during the year was:

2022 2021
Number Number
Total - -

There were no employees whose annual remuneration was more than £60,000.

9 Taxation

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxationof Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.

10 Debtors

Debtors
Amounts falling due within one year:
Trade debtors
Other debtors
Creditors: amounts falling due within one year
Accruals and deferred income		 2022
£
6,000
18,094
24,094
2022
£
2,778		 2021
£
12,500
16,043
28,543
2021
£
3,153

11 Creditors: amounts falling due within one year

THE ASSOCIATION OF CANCER PHYSICIANS

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2022

12 Restricted funds

The restricted fund in relation to the McElwain fund is a separate fund that exists for the award of prizes and scholarships in respect of educational and research studies to advance the objects of the association.

The New Consultants Weekend fund was set up to specifically support senior trainees and consultants in the first 5 years of their appointments. An annual event is held to allow discussions both amongst themselves and with invited more senior mentors about topics facing them at this point in their career.

The Bagshawe Lecture Fund was established following a donation by the trustees of the Post Natal Chorionepithelioma Trust (PNCT) when the charity was dissolved in 2018. The funds support an annual named “Bagshawe” lecture. In 2022 the lecture was given by Dr Martin Pule (UCL) during the ACP Biotherapies Workshop in Leeds in October.

The Interventional Oncology Fund was set up to support a joint interdisciplinary meeting held in October 2021 between the ACP and the British Society of Interventional Oncology (BSIR), to highlight some of the new advances in the rapidly expanding field of interventional oncology. The meeting is being followed up with a book, to be published by EBN Health, due for publication in early 2023.

The Advances in Biotherapies Workshop Fund supported a very successful one-day meeting held in Leeds in October 2022. The workshop showcased some of the recent advances in the rapidly developing field of biotherapies. Presentations from leading experts were complemented with case-based interactive panel discussions. Pharmaceutical sponsorship enabled ACP members to attend the event free of charge.

The ACP Problem Solving in Oncology Webinar fund was set up to support a series of monthly teaching webinars which were launched in October 2020. Sponsored by pharmaceutical companies and hosted on Zoom, the live webinars were initially started to provide additional teaching to compensate for the reduction in local, regional and national educational opportunities during the COVID-19 pandemic. Due to their popularity, the live webinars continue on a monthly basis and are recorded, with the recordings available free of charge to ACP members.

Movement in funds Movement in funds Movement in funds
Balance at Incoming Resources Balance at Incoming
Resources		 Balance at
1 January 2021 resources expended 1 January 2022 resources expended 31 December
2022
£ £ £ £ £ £ £
McElwain 8,290 1 (3,300) 4,991 7 (3,000) 1,998
New
Consultants
Weekend 14,363 14,417 (16,865) 11,915 - - 11,915
Bagshawe
Lecture 29,384 - - 29,384 - (372) 29,012
BSIR
Interventional
Oncology
Study Day
and
Publication - 49,950 (32,758) 17,192 - (5,000) 12,192
Oncology
Webinar
Series - 7,125 (5,376) 1,749 - (7,941) (6,192)
Advances in
Biotherapies
Workshop - - - - 58,750 (62,560) (3,810)
52,037 71,493 (58,299) 65,231 58,757 (78,873) 45,115

THE ASSOCIATION OF CANCER PHYSICIANS

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2022

13
Analysis of net assets between funds
Unrestricted
Restricted
2022
2022
£
£
Fund balances at 31
December 2022 are
represented by:
Current assets/(liabilities)
66,691
45,115
66,691
45,115		 Total Unrestricted
Restricted
2022
2021
2021
£
£
£
111,806
66,277
65,231
111,806
66,277
65,231		 Total
2021
£
131,508
131,508

14 Related party transactions

There were no disclosable related party transactions during the year.